全文获取类型
收费全文 | 24162篇 |
免费 | 1762篇 |
国内免费 | 84篇 |
专业分类
耳鼻咽喉 | 172篇 |
儿科学 | 663篇 |
妇产科学 | 488篇 |
基础医学 | 3169篇 |
口腔科学 | 547篇 |
临床医学 | 2790篇 |
内科学 | 4818篇 |
皮肤病学 | 534篇 |
神经病学 | 2383篇 |
特种医学 | 1157篇 |
外科学 | 3299篇 |
综合类 | 263篇 |
一般理论 | 34篇 |
预防医学 | 2014篇 |
眼科学 | 357篇 |
药学 | 1542篇 |
中国医学 | 45篇 |
肿瘤学 | 1733篇 |
出版年
2023年 | 211篇 |
2022年 | 435篇 |
2021年 | 813篇 |
2020年 | 467篇 |
2019年 | 723篇 |
2018年 | 845篇 |
2017年 | 588篇 |
2016年 | 667篇 |
2015年 | 740篇 |
2014年 | 973篇 |
2013年 | 1294篇 |
2012年 | 1925篇 |
2011年 | 1767篇 |
2010年 | 1018篇 |
2009年 | 1001篇 |
2008年 | 1493篇 |
2007年 | 1524篇 |
2006年 | 1313篇 |
2005年 | 1312篇 |
2004年 | 1196篇 |
2003年 | 1138篇 |
2002年 | 978篇 |
2001年 | 211篇 |
2000年 | 175篇 |
1999年 | 189篇 |
1998年 | 194篇 |
1997年 | 187篇 |
1996年 | 154篇 |
1995年 | 139篇 |
1994年 | 109篇 |
1993年 | 115篇 |
1992年 | 131篇 |
1991年 | 119篇 |
1990年 | 97篇 |
1989年 | 114篇 |
1988年 | 89篇 |
1987年 | 90篇 |
1986年 | 84篇 |
1985年 | 112篇 |
1984年 | 76篇 |
1983年 | 79篇 |
1982年 | 96篇 |
1981年 | 85篇 |
1980年 | 77篇 |
1979年 | 54篇 |
1978年 | 84篇 |
1977年 | 75篇 |
1976年 | 42篇 |
1975年 | 43篇 |
1973年 | 49篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
1.
2.
3.
Sarah Hallas Andrea Nelson Susan O'Meara Una Adderley Pauline Meskell Jane Nixon Aonghus O'Loughlin Sebastian Probst Wael Tawfick Thomas Wild Georgina Gethin 《Journal of tissue viability》2021,30(3):317-323
BackgroundA venous leg ulcer is a chronic leg wound caused by poor venous blood circulation in the lower limbs. It is a recurring condition causing pain, malodour, reduced mobility, and depression. Randomised controlled trials evaluating treatments for venous leg ulcers provide important evidence to inform clinical decision-making. However, for findings to be useful, outcomes need to be clinically meaningful, consistently reported across trials, and fully reported. Research has identified the large number of outcomes reported in venous leg ulcer trials, impacting both synthesis of results, and clinical decision-making. To address this, a core outcome set will be developed. A core outcome set is an agreed standardised set of outcomes which should be, as a minimum, measured and reported in all trials which evaluate treatment effectiveness for a given indication. A core outcome set has the potential to reduce research waste, improve the utility of RCTs, reduce reporting bias, facilitate treatment comparisons across different sources of evidence and expedite the production of systematic reviews, meta-analyses and evidence-based clinical guidelines.AimThe aim of this project is to develop a core outcome set for research evaluating the effectiveness of interventions for treating venous leg ulceration.MethodsThrough a scoping review of the literature on venous leg ulceration, we will firstly identify a list of candidate outcome domains (broad categories in relation to what is being measured) from randomised controlled trials and qualitative research, and outcomes (specific methods in relation to what is being measured). In two further stages, we will use the resulting lists of outcome domains and outcomes to design two online surveys. A range of stakeholders will be invited to participate in the surveys and they will be asked to indicate which outcome domains and outcomes are most important and should be considered as core in future research reports. 相似文献
4.
5.
6.
Sebastian Bonner Thomas Matte Mitchell Rubin Joanne K Fagan Jennifer Ahern David Evans 《The Journal of asthma》2006,43(1):31-35
Although studies have documented underuse of controller medications and overuse of short-acting inhaled ss(2)-agonist among children with persistent asthma in disadvantaged communities, the persistence of oral ss(2)-agonist use in pediatric practice has not been studied since inhaled short-acting ss(2)-agonists became widespread. We describe medications used to treat asthma among children 3 to 5 years of age at 10 Head Start and other subsidized preschool centers in East and Central Harlem, New York City. We interviewed 149 parents/guardians of children who were identified as having probable asthma based on physician's diagnosis, persistent symptoms, hospitalization, and medication use. We classified 86 of the 149 children (58%) as having current persistent asthma. Only 15 of them (17%) were reported to have used controller medications at least 5 days/week in the last 4 weeks-only 2 of whom used inhaled corticosteroids. By contrast, 53 children (62%) used oral ss(2)-agonist in the last 4 weeks, often (72%) in conjunction with nebulized or inhaled short-acting ss(2)-agonist. Use of oral ss(2)-agonist was associated with more severe symptoms. This study documents the continued widespread use of oral ss(2)-agonist for treatment of children in a low-income community with high prevalence of asthma. 相似文献
7.
8.
Bone mineral density testing in healthy postmenopausal women. The role of clinical risk factor assessment in determining fracture risk. 总被引:5,自引:0,他引:5
William D Leslie Colleen Metge Elizabeth A Salamon C Kin Yuen 《Journal of clinical densitometry》2002,5(2):117-130
The ease of measurement and the quantitative nature of bone mineral densitometry (BMD) is clinically appealing. Despite BMD's proven capability to stratify fracture risk, data indicate that clinical risk factors provide complementary information on fracture susceptibility that is independent of BMD. Methods to quantify fracture risk using both clinical and BMD variables would have great appeal for clinical decision-making. We describe a procedure for quantifying hip fracture risk (5-yr and remaining lifetime) based on (1) the individual's age alone (base model, assuming average clinical risk factors and bone density), (2) incorporation of multiple patient-specific clinical risk factor data in the base model, and (3) incorporation of both patient-specific clinical risk factor data and BMD results. 相似文献
9.
10.